Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2006-11-28
2006-11-28
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S001110, C424S001650, C424S009100, C424S009400, C424S001810
Reexamination Certificate
active
07141234
ABSTRACT:
The present invention describes the use of radio-labeled antitumor drugs in the treatment of solid tumors by the method of administering a radio-labelled anticancer drug to a patient and imaging at least a part of the patient using Positron Emission Tomography imaging. The method is used to monitor delivery of antitumor drugs to tumors and may be used to predict the effectiveness of therapy with a particular antitumor drug or combination of antitumor drugs, to assess the effectiveness of modulators of cellular accumulation, to individualize therapy and to evaluate the effectiveness of antitumor drugs with respect to particular cancers. Particularly preferred drugs are labeled taxanes, e.g.,11C-paclitaxel and11C-docetaxel, labeled anthracyclines, e.g.,11C-doxorubicin and11C-epirubicin, and other radio-labeled drug, e.g.11C-topotecan and11C-mitoxantrone. The invention further describes antitumor drugs labeled with the radioactive label11C and methods of preparing radio-labeled drugs.
REFERENCES:
patent: 5981564 (1999-11-01), Page' et al.
patent: 6441025 (2002-08-01), Li et al.
patent: WO 92 19264 (1992-11-01), None
Gottesman, Encyclopedia of Cancer, vol. III, 2002,, Multidrug Resistance I: P-Glycoprotein, pp. 247-254.
Levchenko, A., et al., “Evaluation of 11C-Colchicine for PET Imaging of Multiple Drug Resistance,”Journal of Nuclear Medicine, vol. 41, No. 3, pp. 493-501 (Mar. 2000).
Inoue, Tomio, et al., “Preliminary Study Of Cardiac Accumulation Of F-18 Fluorotamoxifen In patients With Breast Cancer,”Clinical Imaging, vol. 21, pp. 332-336 (1997).
Shields, Anthony F., et al., “Carbon-11-Thymidine and FDG to Measure Therapy Response,”The Journal of Nuclear Medicine, vol. 39, No. 10, pp. 1757-1762 (Oct. 1998).
Kuh, Hyo-Jeong, et al., “Determinants of Paclitaxel Penetration and Accumulation in Human Solid Tumor,”Journal of Pharmacology and Experimental Therapeutics, vol. 290, No. 2, pp. 871-880 (1999).
Schirbel, Anreas, “Synthesis of n.c.a. PET-radiotracers with carbon-11,”Berichte des Forschungszentrums Jülich, 3602, pp. 1-110 (1998).
Kangas, Lauri, et al., “Biodistribution and Scintigraphy of C-Toremifene in Rats Bearing DMBA-Induced Mammary Carcinoma,”Pharmacology&Toxicology, vol. 64, pp. 373-377 (1989).
Hendrikse, N. Harry, et al., “A Newin VitroMethod to Study P-Glycoprotein Transport in Tumors and the Blood-Brain Barrier,”Cancer Research, vol. 59, pp. 2411-1426 (May 15, 1999).
Josien, Hubert, et al., “A General Synthetic Approach to the (20S)-Camptothecin Family of Antitumor Agents by a Regiocontrolled Cascade Radical Cyclization of Aryl Isonitriles,”Chem.—Eur. J., vol. 4(1), pp. 67-83 (1998).
Rao, Ch. Srinivasa, et al., “Synthesis and Evaluation of [14C]-Labelled and Fluorescent-Tagged Paclitaxel Derivatives as New Biological Probes,”Bioorganic&Medicinal Chemistry, vol. 6, pp. 2193-2204 (1998).
Penco, Sergio, et al., “Synthesis of [14-14C] Daunorubicin and Doxorubicin,”Journal of Antibiotics, vol. XXX, No. 9 (Sep. 1977).
Anderson Lawrence
Collins Jerry M.
Klecker Raymond W.
Haddaway Keith G.
Jones Dameron L.
The United States of America as represented by the Department of
Venable LLP
Wiseman Thomas G.
LandOfFree
Imaging of drug accumulation as a guide to antitumor therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imaging of drug accumulation as a guide to antitumor therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging of drug accumulation as a guide to antitumor therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685428